Concepedia

Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach

Malcolm H. Squires, Volkan Adsay, David M. Schuster, Maria C. Russell, Kenneth Cardona, Keith A. Delman, Joshua H. Winer, Deniz Altinel, Juan M. Sarmiento, Bassel F. El‐Rayes,

Annals of Surgical Oncology · 2015 · 104 citations · 17 references

DOI

Concepts

References

17

Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

Jean Claude Reubi, Beatrice Waser, Jean‐Claude Schaer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 651 citations

, , +11

18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors

Tina Binderup, Ulrich Knigge, Annika Loft et al. · Clinical Cancer Research · 2010 · 481 citations · Full text

, , +17

Functional imaging of neuroendocrine tumors with combined PET/CT using <sup>68</sup>Ga‐DOTATATE (DOTA‐<scp>D</scp>Phe<sup>1</sup>,Tyr<sup>3</sup>‐octreotate) and <sup>18</sup>F‐FDG

Irfan Kayani, Jamshed Bomanji, Ashley M. Groves et al. · Cancer · 2008 · 466 citations · Full text

, , +17

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours

Stefan Adams, Richard P. Baum, Thomas Rink et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1997 · 388 citations

, , +12

Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.

Jean Claude Reubi, Larry K. Kvols, Beatrice Waser et al. · PubMed · 1990 · 380 citations

, , +17